| Title: |
Global Oncology: Clinical, social and political challenges |
| Keywords: |
Non-communicable diseases
Health systems
Drugs and vaccines
Cancer
Burden of diseases
|
| Country: |
Germany
|
| Institution: |
Germany - Institute of International Health, Berlin
|
| Course coordinator: |
Dr. med. Oliver Henke
|
| Date start: |
2025-06-16 |
| Date end: |
2025-06-20 |
| About duration and dates: |
One week (“module week”) + three days for a written assignment (submission deadline: two weeks after the end of “module week”) |
| Classification: |
advanced optional
|
| Mode of delivery: |
Face to face
|
Course location:
Institute of Tropical Medicine and International Health,
Charité – Universitätsmedizin Berlin
Campus Virchow-Klinikum
Post address:
Augustenburger Platz 1
D-13353 Berlin, Germany
Visitors’ address:
Augustenburger Platz 1
Campus address: Südring 3b
13353 Berlin, Germany
Phone: +49 (30) 450 565 752
Fax: +49 (30) 450 565 989
Email: mscih-student@charite.de
Website: http://internationalhealth.charite.de/en/
tropEd representative: Dr Hans-Friedemann Kinkel
Email: mscih-coordinator@charite.de |
|
| ECTS credit points: |
2 ECTS credits
|
SIT:
60 hours SIT
Contact: 30 hours (lectures/ workshops/ guided group work), Self-study: 30 hours (12 hours private reading and preparation of presentations during “module week” + 18 hours for written assignment after “module week”) |
|
| Language: |
English
|
Description:
At the end of the module students will be able to
• develop an appropriate strategy for a country or region of choice to improve the response to the growing burden of cancer diseases
• Debate health policy strategies to meet the challenges of the growing cancer burden at a global level and for selected countries
• Describe the basic concept of oncology treatments, prevention and palliative care and analyse necessary prerequisites for the establishment of cancer care in low resource settings
• Describe epidemiological data of cancer diseases in low resource settings and debate the broader health, societal and economic impact of cancer diseases globally and in different countries and regions |
|
Assessment Procedures:
A written assignment (2000-3000 words, accounting 100% to the overall mark).
The assignment assesses the capability of the student to analyse a real world situation and to translate the content of the module into public health approaches.
For the assignment students are asked to select a LMIC country or region within a LMIC country and to:
1. Describe the epidemiology of Cancer diseases in the particular state/region
2. Discuss the Health and Societal Impact of Cancer in the particular state/region
3. Analyse current responses to Cancer at medical and (governmental and non-governmental) political/societal level
4. Develop a strategy to improve the countries response to Cancer and
5. Identify potential barriers for implementation of the proposed interventions
Each student will receive an individual feedback on the assignment and a grade using a rubric matrix. Students pass the assignment if they gain 60% or more of the achievable points. If a student fails the assignment, s/he is allowed to revise and resubmit the assignment considering the comments provided by the marker. |
|
Content:
The course takes on a health systems perspective and focuses on the medico-technical, managerial and policy requirements particularly for diagnosis and treatment of cancer particularly in low- and middle income countries.
The course will cover the following topics:
Day 1 morning: Lecture: “Introduction to the course and topic of Global Oncology” (1h) and
“Basic Introduction to Oncology – entities, diagnostics, staging, treatment modalities” (2h) Lecturer OH
Day 1 afternoon: Lecture: “Cancer epidemiology and “big data” (2h) (NN) and
Workshop “Differences between tropical and non-tropical malignancies” (1h) (OH)
Day 1 evening: Self-study (3 h)
Day 2 morning: Lecture: “Role of Health Education and Prevention” (1h) (OH) and
Lecture and guided group work: “Diagnostics and Treatment impediments – barriers to access” (2 h) (OH and TK)
Day 2 afternoon:
Lecture “Telemedicine (online-tumour boards, telepathology)” (1h) (TK and OH) and
Lecture: “Infection and Cancer diseases” (1h) (TK) and Lecture: “Radiotherapy in developing countries” (1h) (TK) and
Day 2 evening: self-study (3 h)
Day 3 morning: Lecture: “Pharmaceuticals in low resource setting: procurement, approval, availability” (2h) (PV) and guided group work “Minimum standard for handling of cytostatic medications” (1h) (PV and OH)
Day 3 afternoon: Lecture/discussion: “Role of pharmaceutical companies, prizing and access to markets” and “Access to medicine programmes” (2h) (NN) and
Lecture and discussion: “Implications for staff and management in new treatment facilities” (1h) (ZA)
Day 3 evening: Self-study (3 h)
Day 4 morning: Lecture: “Economic burden of Cancer diseases for developing countries” (1h) (DK) and
Lecture/discussion: “Health policy strategies to Cancer diseases” (2h) (DK)
Day 4 afternoon: guided group work: “Universal healthcare coverage and cancer and public private partnership” (2h) (DK and OH) and
Lecture: “Palliative care in low resource settings” (1h) (OH)
Day 4 evening: Self-study and preparation of group work results (3h)
Day 5 morning: Presentations of the group work (1 h) (DK and OH) and
Lecture: “Cancer research in low resource settings” (1h) (DK) and “Future Perspectives for Global Oncology in Academia” (1h) (DK)
Day 5 afternoon: Preparation of assignments for the course (2 h) (OH) and
Session: Feedback and evaluation (1 h) (OH and TK) |
|
Methods:
The course uses participatory learning based on lectures with discussions (24 hrs) and guided group work with presentation (6 hrs) as well as self-directed learning (12 hrs), and a written assignment (18 h) |
|
Prerequisites:
Successful completion of the core course.
English TOEFL test 550 or 213 computer-based or 79/80 internet-based or IELTS band 6.0. |
|
Attendance:
Max. number of students: 20
Students have to attend 85% of the module week. |
|
Selection:
Participants are selected on a first come first served basis. |
|
Fees:
700 € tropEd MScIH students and alumni (For Berlin students who started their studies in 2022 or earlier the old scale of fees applies. Please see here)
875 € guest students (e.g. DIPH and DTMPH candidates) |
|
Scholarships:
None available |
|
tropEd accreditation:
Accredited in EC Conference in December 2019. This accreditation is valid until December 2024. |
|
Remarks:
Preparatory reading is not required.
Course will be sponsored by TAKEDA Pharmaceutical Company Ltd. |
|
| Email Address: |
oliver.henke@charite.de |
| Date Of Record Creation: |
2019-12-06 09:22:17 (W3C-DTF) |
| Date Of Record Release: |
2019-12-06 14:29:33 (W3C-DTF) |
| Date Record Checked: |
2019-12-06 (W3C-DTF) |
| Date Last Modified: |
2024-09-24 09:45:28 (W3C-DTF) |
